acemannan has been researched along with Cytokine Release Syndrome in 1 studies
*Cytokine Release Syndrome: A severe immune reaction characterized by excessive release of CYTOKINES. Symptoms include DYSPNEA; FEVER; HEADACHE; HYPOTENSION; NAUSEA; RASH; TACHYCARDIA; HYPOXIA; HYPERFERRITINEMIA, and MULTIPLE ORGAN FAILURE. It is associated with viral infections, SEPSIS; AUTOIMMUNE DISEASES and a variety of factors used in IMMUNOTHERAPY. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Cong, F; Du, J; Guo, X; Huang, B; Lao, C; Li, D; Li, J; Li, L; Luo, Y; Tong, X; Xu, W; Ye, H | 1 |
1 other study(ies) available for acemannan and Cytokine Release Syndrome
| Article | Year |
|---|---|
Aloe polymeric acemannan inhibits the cytokine storm in mouse pneumonia models by modulating macrophage metabolism.
Topics: Aloe; Animals; Cytokine Release Syndrome; Cytokines; Glycogen Synthase Kinase 3 beta; Lipopolysaccharides; Macrophages; Mannans; Mice; Phosphatidylinositol 3-Kinases; Plant Extracts; Polysaccharides; Proto-Oncogene Proteins c-akt | 2022 |